By Devika Patel
Knoxville, Tenn., March 18 - VentriPoint Diagnostics Ltd. said it raised C$938,927 in the second tranche of a C$2 million private placement of stock.
The deal priced on Feb. 1, and the company raised C$420,085 on March 12.
The company is selling 20 million common shares at C$0.10 per share. It sold 4,200,853 shares in the first tranche and 9,389,270 shares in this one.
Proceeds will be used for the product and service commercialization of the VentriPoint Medical System, the expansion of applications to include additional diagnoses and heart diseases and for general working capital.
Based in Calgary, Alta., VentriPoint is a clinical diagnostic company.
| Issuer: | VentriPoint Diagnostics Ltd.
|
| Issue: | Common shares
|
| Amount: | C$2 million
|
| Shares: | 20 million
|
| Price: | C$0.10
|
| Warrants: | No
|
| Pricing date: | Feb. 1
|
| Settlement date: | March 12 (for C$420,085), March 18 (for C$938,927)
|
| Stock symbol: | TSX Venture: VPT
|
| Stock price: | C$0.115 at close Jan. 29
|
| Market capitalization: | C$6.01 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
